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A B S T R A C T
Introduction. Pharmacists play a key role while dispensing over-the-counter emergency contraception (EC) to the
client.
Aims. The study aims to evaluate the knowledge and over-the-counter services provided by the pharmacists in
Delhi.
Methods. A prestructured questionnaire-based survey was conducted in Delhi, the capital city of India.
Results. Only 60 out of 85 pharmacies approached agreed to participate in the study. Number of packs sold in a
month per pharmacy varied from 2 to 500 packs/month. Sixty-two percent of the pharmacists claimed that majority
of the clients repeated use during the same month. Only 18% of the clients were referred by doctors while 82%
directly approached the pharmacists. Nearly one third of the clients were adolescents. Sixty-seven percent of the
pharmacists had adequate knowledge about EC. Only 3.3% asked about the last menstrual period or the time elapsed
since the last unprotected intercourse. No pharmacist inquired whether there were one or multiple unprotected acts
of intercourse, if any regular contraceptive method was being used, or explored the reason for EC intake. There were
91.7% who explained the dosage schedule to clients. Only half of them explained that the client may experience side
effects. None of the pharmacists advised their clients for a sexually transmitted disease screening, and 35% counseled
the clients regarding regular contraception.
Conclusion. Improving the quality of services provided by the pharmacists can clear misconceptions of the clients
and promote subsequent regular contraception along with precautions to avoid sexually transmitted diseases.Mishra
A and Saxena P. Over-the-counter sale of emergency contraception: A survey of pharmacists in Delhi. Sex
Med 2013;1:16–20.
Key Words. Pharmacists; Emergency Contraception; Over the Counter
Introduction
Emergency contraception (EC) is deﬁned asthe use of contraceptive method after inter-
course to prevent unintended pregnancy, and it is
indicated in situations like sexual assault, incest,
failure of barrier contraceptive, or after an unpro-
tected intercourse.
The Drug Controller General of India
approved levonorgestrel, a progestin-only pill, as
the dedicated product for EC in 2001. It was
included in a national family planning program in
2003. EC was made available over the counter in
2005 but its popularity increased in urban young
women after 2007 due to mass advertising efforts
of manufacturer companies.
Over-the-counter availability of EC was an
important step taken by the Government of India
to popularize its use in the country in order to
reduce the rate of unwanted pregnancies which
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would bring down the rate of abortions and asso-
ciated maternal morbidity and mortality. ECs
taken within 72 hours of an unprotected inter-
course are 75–85% effective [1]. At present there
are seven EC pills available in the Indian market,
all of them are sold over the counter. Their cost is
about 1.84 USD per pack.
According to service delivery guidelines of Min-
istry of Health and Family Welfare, emergency
contraceptive pills can be dispensed by doctors,
nurses, midwives, pharmacists, paramedics, family
welfare assistants, and other clinically trained per-
sonnel as well as community health workers in
order to improve their widespread use. However,
all providers should be appropriately informed
about EC and should also counsel the clients for
regular contraceptive usage [2].
The sale of EC has increased manifold. Most
clients prefer to obtain EC through drugstores
rather than medical facilities, although EC is avail-
able free of cost in public sector [3,4]. No previous
published study has assessed the knowledge and
practices of pharmacists for dispensing EC in
India. Therefore, we conducted this study to
evaluate the knowledge and over-the-counter ser-
vices provided by the pharmacists in an urban city
of India.
Methods
This was a prestructured questionnaire-based
survey conducted in Delhi, the capital city of India.
A total of 85 pharmacies situated in nine districts
of Delhi were approached by a team of doctors.
Only 60 out of 85 pharmacies approached agreed
to participate in the study after ensuring conﬁden-
tiality. Of the 25 pharmacies who refused to par-
ticipate in the study, all were privately owned
in urban or semi-urban areas. Six pharmacists
informed that they did not dispense emergency
contraceptives or any abortifacient on moral
grounds; three pharmacies were small and sup-
plied limited medications. Two pharmacies refused
to participate in the study although they dispensed
EC because they were not sure whether over-the-
counter sale of EC was legally permitted and
viewed the investigators with suspicion even after
reassurance. Fourteen busy pharmacists refused to
participate as they were placed near big hospitals
and could not spare any time for this interview.
A team of ﬁve female doctors were trained to
conduct the interview. The questionnaire was pre-
tested before initiating the study. Any one of these
ﬁve conducted the interview. A written question-
naire in both English and Hindi (local language)
was handed over to the pharmacists for ﬁlling after
explaining the purpose of the study, but the sur-
veyors were always available to explain if there was
any query in the mind of the pharmacists.
The prestructured proforma consisted of 14
questions along with an extra column for any
special remark or any additional information pro-
vided by the pharmacists (see Appendix). Filled
proforma were collected on the spot and no incen-
tive money was paid. As this study did not involve
patients, approval from ethical committee was not
obtained.
During interview, knowledge of pharmacist was
judged. It was considered to be adequate if they
knew about the EC constituents, indications of use,
mode of action, dosage schedule, time duration
during which it could be taken, side effects, may
lead to failure, should be used only for emergency
purposes, and cannot be used as a regular contra-
ception. If any of these was lacking, the knowledge
of the pharmacist was considered inadequate.
Results
Response rate of participating pharmacists was
70.6%, i.e., 60 out of 85 approached agreed to
participate in the study. Number of packs sold in a
month per pharmacy varied from 2 to 500 packs/
month, with a mean of 62 packs every month.
Thirty-eight pharmacists claimed that clients took
the EC once every month while the rest (62%)
claimed that majority of the clients repeated use
during the same month. Two pharmacists reported
that the same clients bought pack of EC as high as
even 30 times a month (Figure 1).
Levonorgestrel 1.5 mg single dose within 72
hours is the most preferred regimen. Eighteen
percent of the clients were referred by doctors
while 82% directly approached the pharmacists
(Figure 2). There was a nearly equal clientele of
both sexes, with 47% females and 53% males
approaching the pharmacy.
Nearly one third of the clients were adolescents.
The duration of the interaction between the phar-
macist and the client ranged from 2 to 10 minutes,
with an average of 5 minutes. Sixty-seven percent
(40/60) of the pharmacists had adequate knowledge
about EC. According to most pharmacists, they
could communicate more freely with male custom-
ers as compared with female customers because
they did not want to embarrass or lose the latter.
Information regarding discussion of pharma-
cists with clients is shown in Figure 3. Only two
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pharmacists (3.33%) asked about the last men-
strual period or the time elapsed since the last
unprotected intercourse. No pharmacist inquired
whether there were one or multiple unprotected
acts of intercourse. None of them asked if any
regular contraceptive method was being used or
explored the reason for EC intake like bursting of
condom or oral contraceptive missing.
While dispensing of the EC, 55/60 (91.7%)
explained the dosage schedule to clients. Thirty
(50%) explained that the client may experience
nausea or vomiting. Three (5%) advised the clients
to take EC with antacids or anti-emetics. None of
them advised the client to repeat the dose of EC in
case of vomiting within 2 hours of intake.
Thirty-two (53.3%) explained that the client
may conceive in spite of consuming the medicine.
Thirty-eight (63.3%) explained that repeat intake
of ECs is harmful to the client. None of the phar-
macists advised their clients for a sexually trans-
mitted disease (STD) screening. Only 35% (21/
60) counseled the clients regarding regular
contraception. Five percent (3/60) advised regard-
ing condoms while 30% (18/60) advised regarding
both condom and oral contraceptives. According
to all pharmacists, no patient reported back to
them with failure of contraception.
Discussion
In 1960, the ﬁrst clinical trials of hormone
emergency contraceptive were conducted using
high-dose estrogen hormone. In 1970, Yuzpe
method was initiated using high-dose combined
oral contraceptive containing ethinyl estradiol,
and levonorgestrel. Nowadays available options
of emergency contraceptive methods are
Levonorgestrel (0.75 mg, 2 tabs 12 hours apart or
1.5 mg single dose), danazol, mifeprestone, and
intrauterine contraceptive device. Mechanism of
action of EC depends on the phase of menstrual
cycle. Suggested mechanisms of action are inhibi-
tion of or delayed ovulation, prevention of implan-
tation, fertilization or dysynchrony in transport of
the sperms or ovum. Levonorgestrel-containing
preparations are found to exhibit fewer side effects
with identical efﬁcacy to Yuzpe method and are the
dedicated EC in India [5].
Concerns that easy access to EC may lead to
careless sexual behavior have been dispelled [5]. A
number of studies have now demonstrated that
facilitating access neither reduces compliance with
contraceptive use nor increases rates of unpro-
tected sexual intercourse or sexually transmitted
infections (STIs) [3,6,7]. However, no study has
demonstrated that increased availability of EC
reduces unintended pregnancy rates. At a popula-
tion level, it is becoming apparent that improved
access to EC has no signiﬁcant impact on abortion
rates [7–9].
A recent study on the impact of increased access
to EC concluded that, ultimately, the greatest
health beneﬁt of EC may be achieved indirectly by
health workers counseling women at the time they
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present for procuring EC to improve use of their
current method or to change to a more reliable
method [9,10].
Pharmacists play a key role in providing emer-
gency contraception services and it is essential
that they have comprehensive and correct knowl-
edge about the methods available. Only 67%
(40/60) of the pharmacists had adequate knowl-
edge about EC. They can carry out the role of
supplying EC with good counseling only if they
have correct knowledge, which would reduce
maternal mortality and morbidity due to
unwanted pregnancies.
Most of the pharmacists interviewed in this
study did not have a separate private area to
conduct counseling for the clients although nearly
two thirds (67%) had adequate knowledge about
ECs. Fifty-ﬁve out of sixty pharmacists (91.7%)
were clear about the differences between EC and
medical abortions, which is a method for inducing
early abortion by means of drugs. Still, only two of
them inquired about the last menstrual cycle or the
time elapsed since coitus and dispensed EC
without ruling out pregnancy.
The reasons for not providing adequate coun-
seling to the clients were lack of privacy during
conversation, lack of time or knowledge, to avoid
embarrassment to the clients, or to avoid the risk
of losing the customer in the future.
Over-the-counter availability has increased use
of EC due to avoidance of embarrassment and easy
accessibility round the clock, but full potential of
pharmacists has not been utilized. Another impor-
tant fact is that hardly any clients are approaching
public sector facilities for procuring EC even
though it is supplied free of cost. Other advantages
of obtaining EC from medical facilities would be
correct information regarding use of EC along
with advice regarding regular contraception, STD
screening, and future protection from infection
transmission.
Most of the pharmacists are not encouraging
their clients to use regular contraception. They are
also not advising them regarding protection from
STIs by use of condoms. It is alarming that EC is
being used more frequently as means of avoiding
pregnancies rather than using regular family plan-
ning methods. Low efﬁcacy and signiﬁcantly
higher side effects of EC as compared with regular
contraception need to be emphasized by the phar-
macists to avoid repeat usage by the clients.
The limitations of this study are that the results
are based on the self-report by a pharmacist which
implies that the practices in this study may be a
proxy for actual practices while dispensing EC.
Also, the results of this study cannot be general-
ized to all pharmacists in India.
Pharmacists should not miss any opportunity to
guide and educate their clients as they are some-
times the ﬁrst or only contact of client to a health
professional. At the same time, it is to be remem-
bered that unlike medical facilities, pharmacies are
proﬁt-making, private-owned places where they
desire more frequent, speedy, conﬁdential, and
costly transactions (EC is more costly than oral
contraceptive pills). Therefore the interest of both
pharmacist and clients have to be balanced and
protected.
Certain steps to improve pharmacy services
could be inclusion of EC-related knowledge and
services in their curriculum in order to impart
correct knowledge and sensitize them for appro-
priate counseling for subsequent sexual behavior.
Short-term refresher training can also be intro-
duced. Close links should be developed between
clinicians and pharmacists for smooth exchange of
referrals. Leaﬂets containing correct information
regarding emergency contraceptive and promo-
tion of regular contraception can be provided to
the customers along with emergency contraceptive
pills. Mass media should help in behavior-
changing communication and understanding need
of regular contraception.
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Appendix
Prestructured Questionnaire for Pharmacists
Name of the Chemist Address:
1 How many packs of EC are sold in 1 month?
2 How many clients come with prescription?
3 What is the gender of the clients?
4 What percentage of clients are adolescents?
5 Knowledge of pharmacists:
A What are the constituents of EC pill?
B What is the indication of use of EC pill?
C What is the mode of action of EC pill?
D Time limit for EC intake after unprotected act of
intercourse
E Dosage schedule
F Side effect of EC
G Can a woman conceive in spite of taking EC?
H Should EC be used for emergency/regular contraception?
6 Do you understand the difference between emergency contra-
ception and medical abortion?
7 Do clients come for buying EC more than once a month?
8 Maximum number of times clients come for buying EC/month
9 Which is the most preferred regimen of EC?
10 Time spent during interaction between the client and the
pharmacist
11 Do you inquire the client about the following while dispensing
EC?
A Last menstrual period
B Time elapsed since last unprotected act of intercourse
C Single or multiple acts of unprotected intercourse
D Whether there have been other acts of unprotected inter-
course 72 hours prior to intake of EC
E Whether client was using regular contraception
12 While dispensing EC do you counsel the client regarding:
A Dosage Schedule?—Yes/No
B Expected side effects like nausea and vomiting?—Yes/No
C Taking EC along with antacid/anti-emetics?—Yes/No
D Repeating EC in case of vomiting within 2 hours?—Yes/No
E That frequent intake of EC may be harmful?—Yes/No
F STD screening by a medical practitioner?—Yes/No
G Advice to use regular contraception in future?—Yes/No. If
yes, which one?
H That client may conceive in spite of consuming EC?
13 Does any patient report to you if they conceive even after EC
intake?
14 Reasons for not providing adequate counseling to the clients
20 Mishra and Saxena
Sex Med 2013;1:16–20 © 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
